To amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited provisional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes.
About This Bill
Committee
Latest Action · June 8, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.